Optic Neuritis

Improvement in Acute Optic Neuritis Similar With IV, Oral Corticosteroids

Improvement in Acute Optic Neuritis Similar With IV, Oral Corticosteroids

By

The advantages of oral prednisone include "being less expensive and more convenient to access and administer and [being] preferred by patients to [intravenous] methylprednisolone."

Inter-Eye Percentage Difference May Help Diagnose MS-Associated Optic Neuritis

Inter-Eye Percentage Difference May Help Diagnose MS-Associated Optic Neuritis

By

Using the inter-eye percentage difference may help surpass limitations associated with device and proprietary segmentation algorithms.

RENEW Trial: Promising Results for Optic Neuritis Treatment

RENEW Trial: Promising Results for Optic Neuritis Treatment

By

Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.

Radiation Dose Influences Optic Neuropathy Risk

Radiation Dose Influences Optic Neuropathy Risk

There were no significant associations for alternative risk factors after controlling for radiation dosage.

Anterior Visual Pathway Measures and Cognition in MS

Anterior Visual Pathway Measures and Cognition in MS

By

There was a significant association between the average GCIP thickness and MSFC scores.

Antihistamine May Benefit Optic Neuropathy in Multiple Sclerosis

Antihistamine May Benefit Optic Neuropathy in Multiple Sclerosis

While the effect is modest, researchers believe the findings will influence future repair studies.

Epilepsy Drug May Be Neuroprotective in Optic Neuritis

Epilepsy Drug May Be Neuroprotective in Optic Neuritis

By

Those treated with phenytoin saw a 30% reduction in retinal nerve fiber loss.

Anti-LINGO-1 May Repair Myelin Damage in Multiple Sclerosis

Anti-LINGO-1 May Repair Myelin Damage in Multiple Sclerosis

The drug was tested in patients with optic neuritis, but is now being evaluated in patients with multiple sclerosis.

Remyelination Agent for Optic Neuritis Shows Limited Success

Remyelination Agent for Optic Neuritis Shows Limited Success

An anti-LINGO-1 monoclonal antibody showed some success in treating optic neuritis but missed many study endpoints.

Sign Up for Free e-newsletters



CME Focus